MD3927G2 - Metodă de tratament al paraliziei faciale - Google Patents
Metodă de tratament al paraliziei faciale Download PDFInfo
- Publication number
- MD3927G2 MD3927G2 MDA20080102A MD20080102A MD3927G2 MD 3927 G2 MD3927 G2 MD 3927G2 MD A20080102 A MDA20080102 A MD A20080102A MD 20080102 A MD20080102 A MD 20080102A MD 3927 G2 MD3927 G2 MD 3927G2
- Authority
- MD
- Moldova
- Prior art keywords
- days
- daily
- compositum
- day
- biologically active
- Prior art date
Links
- 208000004929 Facial Paralysis Diseases 0.000 title abstract 2
- 208000036826 VIIth nerve paralysis Diseases 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 230000002354 daily effect Effects 0.000 abstract 4
- 238000002360 preparation method Methods 0.000 abstract 4
- 239000007924 injection Substances 0.000 abstract 2
- 238000002347 injection Methods 0.000 abstract 2
- 241000258180 Echinacea <Echinodermata> Species 0.000 abstract 1
- 239000009993 Lymphomyosot Substances 0.000 abstract 1
- 210000004720 cerebrum Anatomy 0.000 abstract 1
- 239000005515 coenzyme Substances 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 235000014134 echinacea Nutrition 0.000 abstract 1
- 230000003203 everyday effect Effects 0.000 abstract 1
- SOECUQMRSRVZQQ-UHFFFAOYSA-N ubiquinone-1 Chemical compound COC1=C(OC)C(=O)C(CC=C(C)C)=C(C)C1=O SOECUQMRSRVZQQ-UHFFFAOYSA-N 0.000 abstract 1
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Invenţia se referă la medicină, neurologie, pediatrie şi este destinată tratamentului paraliziei faciale la nou-născuţi, sugari, copii şi maturi.Metoda, conform invenţiei, constă în aceea căse administrează per os preparatele Bryaconeel şi Engystol N câte ¼…1 pastilă, Lymphomyosot şi Galium-Heel câte 3…10 picături timp de 1 lună de 3 ori pe zi şi subcutanat preparatele Traumeel S câte 0,3…2,2 ml zilnic în primele 3 zile, apoi peste 1 zi, Cerebrum compositum N câte 0,3…2,2 ml zilnic în primele 2 zile, apoi peste 2 zile, Gelsemium-Homaccord câte 0,3…1,1 ml zilnic în primele 3 zile, apoi peste 2 zile, Aconitum-Homaccord câte 0,3…1,1 ml zilnic în primele 3 zile, apoi peste 2 zile, Echinacea compositum S câte 0,3…2,2 ml de 2 ori pe săptămână, la o serie de tratament de 7…10 injecţii, precum şi Coenzyme compositum şi Ubichinon compositum câte 0,3…2,2 ml o dată pe săptămână, la o serie de tratament de 2…4 injecţii. Totodată, preparatele menţionate se administrează în următoarele puncte biologic active: E1,2,3,4,6,7,8,36,44; V1,2,3, 10,11,60; VB1,3,14,20,21,34,39; TR23; IG18; GI19,20; T 14, 26,27; G14,10,11; AP11,14,33,35,37; J24; P7; RP6. În fiecare punct biologic activ se introduce un singur preparat medicamentos, care se administrează câte 0,1…0,4 ml în 3…5 puncte, totodată în fiecare zi se selectează diferite puncte biologic active.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MDA20080102A MD3927G2 (ro) | 2008-04-07 | 2008-04-07 | Metodă de tratament al paraliziei faciale |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MDA20080102A MD3927G2 (ro) | 2008-04-07 | 2008-04-07 | Metodă de tratament al paraliziei faciale |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MD3927F1 MD3927F1 (ro) | 2009-06-30 |
| MD3927G2 true MD3927G2 (ro) | 2010-01-31 |
Family
ID=40942304
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MDA20080102A MD3927G2 (ro) | 2008-04-07 | 2008-04-07 | Metodă de tratament al paraliziei faciale |
Country Status (1)
| Country | Link |
|---|---|
| MD (1) | MD3927G2 (ro) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SU1483373A1 (ru) * | 1986-10-17 | 1989-05-30 | Всесоюзный научно-исследовательский центр по охране здоровь матери и ребенка | Способ прогнозировани нарушени мозгового кровообращени у новорожденных |
| RU2164082C1 (ru) * | 2000-03-07 | 2001-03-20 | Новокузнецкий государственный институт усовершенствования врачей | Способ диагностики состояния центральной нервной системы плода |
| UA78490C2 (en) * | 2002-11-12 | 2007-04-10 | Univ Odesa State Medical | Method for predicting and treating facial paralysis |
-
2008
- 2008-04-07 MD MDA20080102A patent/MD3927G2/ro not_active IP Right Cessation
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SU1483373A1 (ru) * | 1986-10-17 | 1989-05-30 | Всесоюзный научно-исследовательский центр по охране здоровь матери и ребенка | Способ прогнозировани нарушени мозгового кровообращени у новорожденных |
| RU2164082C1 (ru) * | 2000-03-07 | 2001-03-20 | Новокузнецкий государственный институт усовершенствования врачей | Способ диагностики состояния центральной нервной системы плода |
| UA78490C2 (en) * | 2002-11-12 | 2007-04-10 | Univ Odesa State Medical | Method for predicting and treating facial paralysis |
Also Published As
| Publication number | Publication date |
|---|---|
| MD3927F1 (ro) | 2009-06-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013542195A5 (ro) | ||
| HRP20140783T1 (hr) | Uporaba epotilona d u lijeäśenju tau-povezanih bolesti ukljuäśujuä†i alzheimerovu bolest | |
| HRP20192189T1 (hr) | Doziranja i terapijske primjene l-4-klorokinurenina | |
| WO2023169439A1 (zh) | 一种维生素ad口溶膜组合物、其制备方法及应用 | |
| MD3927G2 (ro) | Metodă de tratament al paraliziei faciale | |
| Scheerens et al. | Treatment with MEMP1972A, an anti-M1 prime monoclonal antibody, reduced serum IgE in healthy volunteers and patients with allergic rhinitis | |
| MD3803G2 (ro) | Metodă de tratament al hiperchineziilor la copii | |
| US20240207371A1 (en) | Superoxide dismutase compositions and methods | |
| EP3576754B1 (en) | Intranasal composition of methylcobalamin | |
| Ananth et al. | Benztropine psychosis | |
| MD3940G2 (ro) | Metodă de tratament al paraliziei plexului brahial | |
| MD3906G2 (ro) | Metodă de tratament al enurezisului nevrotic la copii | |
| CN105232577A (zh) | 一种脂肪来源干细胞因子的生发技术 | |
| Ghaffar et al. | Effects of zinc and multivitamins supplements on growth in school children: zinc and multivitamins supplements on growth in school children | |
| US20230295585A1 (en) | Superoxide dismutase compositions and methods | |
| RU2005136271A (ru) | Способ диагностики и лечения неврологических повреждений у детей раннего возраста | |
| Tanwandee et al. | Pharmacokinetics, safety and tolerability of tenofovir exalidex, a novel prodrug of tenofovir, administered as ascending multiple doses to healthy volunteers and HBV-infected subjects | |
| CN105801684A (zh) | 重组人生长激素及其促进卵泡发育的应用 | |
| Cutter et al. | (DXT24) Two Expanded Disability Status Scale Subscales Evaluated in Patients with Relapsing-Remitting or Secondary Progressive Multiple Sclerosis. | |
| CN103637979A (zh) | 一种匹多莫德口服液 | |
| CN103638021A (zh) | 一种匹多莫德口服液的制备方法 | |
| CN107149609B (zh) | 紫菜多糖在制备治疗手足口病毒感染的药物中的应用 | |
| ROSEA | PITYRIASIS ALBA | |
| CN103099823A (zh) | 一种抗乙肝的药用组合物及其制备方法、用途 | |
| Vedanayagam | Hyaluronic acid |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG4A | Patent for invention issued | ||
| KA4A | Patent for invention lapsed due to non-payment of fees (with right of restoration) | ||
| MM4A | Patent for invention definitely lapsed due to non-payment of fees |